Publications by authors named "Mauro Santolamazza"
Article Synopsis
- Study aimed to improve hepatitis C treatment in older patients using amantadine (AH) alongside interferon (IFN) due to IFN's side effects.
- Out of 165 patients over 65 who had not responded to previous IFN treatments, three groups were formed: Group A received only AH, Group B received IFN alone, and Group C received both AH and IFN.
- Results showed that Group C had the highest percentage of patients achieving normal ALT levels and negative HCV-RNA, suggesting that the combination treatment was more effective and reduced side effects from IFN.
